Pharmacokinetic behavior of argirein, derived from rhein, is characterized as slow release and prolonged T1/2 of rhein in rats
Authors:
- Peng-Rong FuPFPeng-Rong Fu
- De-Zai DaiDDDe-Zai Dai
- Yun ZhangYZYun Zhang
- Yin DaiYDYin Dai
- 1 August 2012
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 46 (5) , 468-474
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Activation of AQP4, p66Shc and endoplasmic reticulum stress is involved in inflammation by carrageenan and is suppressed by argirein, a derivative of rheinJournal of Pharmacy and Pharmacology, 2012
- ER Stress, P66shc, and P-Akt/Akt Mediate Adjuvant-Induced Inflammation, Which Is Blunted by Argirein, a Supermolecule and Rhein in RatsInflammation, 2011
- Argirein alleviates diabetic nephropathy through attenuating NADPH oxidase, Cx43, and PERK in renal tissueNaunyn-Schmiedeberg's Archives of Pharmacology, 2011
- Rhein Improves Renal Lesion and Ameliorates Dyslipidemia in db/db Mice with Diabetic NephropathyPlanta Medica, 2009
- Pharmacokinetic Study of Rhein and its Carboxyl-esterification Derivatives in RatsChinese Journal of Natural Medicines, 2009
- Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodellingArthritis Research & Therapy, 2008
- Clinical Pharmacokinetics of DiacereinClinical Pharmacokinetics, 1998
- Vascular Effects of Acute Hyperglycemia in Humans Are Reversed byl-ArginineCirculation, 1997
- Influence of renal function on the pharmacokinetics of diacerein after a single oral doseEuropean Journal of Drug Metabolism and Pharmacokinetics, 1994
- Influence of renal function on the pharmacokinetics of diacerein after a single oral doseFundamental & Clinical Pharmacology, 1993